Advertisement

Polio Eradication at Risk as US Funding Cuts Threaten Global Health Efforts
Healthy

LONDON — The global fight to eliminate polio faces significant setbacks due to drastic funding cuts from the United States, which could delay eradication efforts and leave more children vulnerable to paralysis, warns a top World Health Organization (WHO) official.

The WHO, alongside key partners like UNICEF and the Bill & Melinda Gates Foundation, has been leading the charge to wipe out polio worldwide. However, recent financial withdrawals by the U.S.—including a 90% reduction in USAID grants—have disrupted critical programs. This move aligns with President Donald Trump’s "America First" policy and includes halting collaboration with the U.S. Centers for Disease Control and Prevention (CDC).

Hamid Jafari, director of WHO’s polio eradication program for the Eastern Mediterranean region—which includes Afghanistan and Pakistan, where wild poliovirus remains active—revealed that $133 million in expected U.S. funding this year has vanished. "If this gap persists," he said, "we risk prolonging eradication timelines and seeing more children paralyzed." He emphasized that delays would only drive costs higher.

The financial shortfall threatens essential operations such as disease surveillance and staffing but will not impact vaccination campaigns in high-risk countries like Afghanistan and Pakistan. Jafari confirmed that partners are seeking alternative funding sources to sustain critical activities while hoping for renewed U.S. support.

Saudi Arabia recently stepped up with a $500 million pledge toward polio eradication last week—a welcome boost but insufficient alone to cover deficits. Meanwhile, UNICEF declined comment on its terminated grant status while a Gates Foundation spokesperson stressed that no single organization can replace lost U.S. contributions.

The Global Polio Eradication Initiative already faces an uphill battle: last year’s reassessment projected an additional $2.4 billion would be needed by 2029 due to extended timelines for eliminating transmission completely.

Hot News
Father-Daughter Duo's Inspiring Health Transformation: How Small Steps Led to Big Changes
Father-Daughter Duo's Inspiring Health Transformation: How Small Steps Led to Big Changes
Starting a healthier lifestyle often feels overwhelming, but as one father-daughter team discovered, the journey becomes much easier with the right support system and simple first steps. Their heartwarming story proves that positive change is within everyone's reach.
More>>
Global Air Quality Crisis: Only 7 Nations Meet WHO Standards as US Monitoring Cuts Loom
Global Air Quality Crisis: Only 7 Nations Meet WHO Standards as US Monitoring Cuts Loom
SINGAPORE — In a startling revelation about the state of our planet's air, just seven countries worldwide met the World Health Organisation's (WHO) stringent air quality benchmarks last year. This alarming data comes as environmental researchers sound the alarm about worsening pollution tracking capabilities following the shutdown of crucial US-led global monitoring initiatives.
More>>
Scientists Discover Bat Virus with Similar Traits to Covid-19, But Risk of Human Spread Remains Low
Scientists Discover Bat Virus with Similar Traits to Covid-19, But Risk of Human Spread Remains Low
Chinese researchers have identified a bat coronavirus that shares a key trait with the virus behind Covid-19—it uses the same ACE2 receptor to invade human cells. While this raises concerns about potential future transmission, experts caution against alarm, as the virus currently shows limited ability to infect humans.
More>>
FDA Experts Unanimously Back JN.1-Targeted COVID Vaccines for 2026-2026 Season
FDA Experts Unanimously Back JN.1-Targeted COVID Vaccines for 2026-2026 Season
In a decisive move to stay ahead of the evolving pandemic, US Food and Drug Administration (FDA) advisory panel members voted unanimously on Thursday (May 22) to recommend next-generation COVID-19 vaccines specifically designed to combat emerging JN.1 variant strains for the 2026-2026 immunization campaign.
More>>